Aurora Cannabis, a Canadian company that is at the forefront of the development and advancement of consumer and industry-targeted cannabinoid (CBD) products, has launched a new cannabis oil product in Uruguay that is truly a trailblazer in that it is the first product of its kind in that country to be produced completely domestically.
Available in two different options in the form of three percent and 10 percent concentrations, the 'Bidiol' medical cannabis oil is available in 10ml and 30ml bottles in pharmacies across Uruguay, which has authorized the substance for treatment of epilepsy.
Aurora Cannabis has stated that the launch of Bidiol cannabis oil in Uruguay could be a start of bigger things to come, with the company well and truly looking to make inroads in the South American cannabis market.
Domestically Sourced Cannabis Oils
The 'Bidiol' CBD Oil Is Sold and Produced In Uruguay
Trend Themes
1. Domestically Sourced Cannabis Oils - Companies can explore producing cannabis oils domestically, rather than importing them.
2. Targeted Cannabinoid Products - More companies can develop consumer and industry-targeted cannabinoid products by capitalizing on the legalization of cannabis.
3. Expansion Into South American Cannabis Market - Companies can expand into the South American cannabis market as more countries legalize the use of cannabis.
Industry Implications
1. Cannabis Industry - Cannabis companies can develop new products and explore foreign markets.
2. Pharmaceutical Industry - Pharmaceutical companies can explore the use of CBD oil in the treatment of epilepsy and other health conditions.
3. Agriculture Industry - Companies involved in agriculture can explore the potential of growing domestic cannabis for medicinal and recreational purposes.